Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation

• Published in: Cancers 2018-10, Vol.10 (10), p.378
• Main Authors: Chen, Jinbin, Peng, Kangqiang, Hu, Dandan, Shen, Jingxian, Zhou, Zhongguo, Xu, Li, Chen, Jiancong, Pan, Yangxun, Wang, Juncheng, Zhang, Yaojun, Chen, Minshan
• Format: Article
• Language: English
• Subjects: Cancer therapies; Hepatocellular carcinoma; Liver cancer; Medical prognosis; Nodules; Patients; Radiofrequency ablation; Survival; Veins & arteries
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers10100378

Radiofrequency ablation (RFA) is recommended as a first-line therapy for small hepatocellular carcinoma (HCC). Tumor location is a potential factor influencing the procedure of RFA. To compare oncologic outcomes of RFA for different tumor locations, this retrospective study enrolled 194 patients with small HCC who had undertaken RFA. The HCC nodules were classified as peri-hepatic-vein (pHV) or non-pHV, peri-portal-vein (pPV) or non-pPV, and subcapsular or non-subcapsular HCC. The regional recurrence-free survival (rRFS), overall survival (OS), recurrence-free survival (recurrence in any location, RFS) and distant recurrence-free survival (dRFS) were compared. Operation failures were recorded in five pPV HCC patients, which was more frequent than in non-pPV HCC patients ( = 0.041). The 1-, 3-, and 5-year rRFS was 68.7%, 53.7%, and 53.7% for pHV patients and 85.1%, 76.1%, and 71.9% for non-pHV patients, respectively ( = 0.012). After propensity score matching, the 1-, 3-, and 5-year rRFS was still worse than that of non-pHV patients ( = 0.013). The OS, RFS, and dRFS were not significantly different between groups. A pHV location was a risk factor for the regional recurrence after RFA in small HCC patients. The tumor location may not influence OS, RFS, and dRFS. Additionally, a pPV location was a potential high-risk factor for incomplete ablation.